RT Journal Article
SR Electronic
T1 Structural and diffusion weighted brain imaging biomarkers for ADHD and its symptomology in very young (4–7-year-old) children
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.23.21263990
DO 10.1101/2021.09.23.21263990
A1 Öztekin, Ilke
A1 Garic, Dea
A1 Finlayson, Mark A.
A1 Graziano, Paulo A.
A1 Dick, Anthony Steven
YR 2021
UL http://medrxiv.org/content/early/2021/09/26/2021.09.23.21263990.abstract
AB The current study aimed to identify the key neurobiology of Attention-Deficit/Hyperactivity Disorder (ADHD), as it relates to ADHD diagnostic category and symptoms of hyperactive/impulsive behavior and inattention. To do so, we adapted a predictive modeling approach to identify the key structural and diffusion weighted brain imaging measures, and their relative standing with respect to teacher ratings of executive function – EF (measured by the Metacognition Index of the Behavior Rating Inventory of Executive Function– BRIEF), negativity and emotion regulation – ER (measured by the Emotion Regulation Checklist, ERC), in a critical young age range (ages 4 to 7, mean age 5.52 years, 82.2% Hispanic/Latino), where initial contact with educators and clinicians typically take place. Teacher ratings of EF and ER were predictive of both ADHD diagnostic category and symptoms of hyperactive/impulsive behavior and inattention. Among the neural measures evaluated, the current study identified the critical importance of the largely understudied diffusion weighted imaging measures for the underlying neurobiology of ADHD and its associated symptomology. Specifically, our analyses implicated the inferior frontal gyrus, the pericallosal sulcus, and the caudate as critical predictors of ADHD diagnostic category and its associated symptomology, above and beyond teacher ratings of EF and ER. Collectively, the current set of findings have implications for theories of ADHD, the relative utility of neurobiological measures with respect to teacher ratings of EF and ER, and the developmental trajectory of its underlying neurobiology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe AHEAD study is funded by grants from the National Institute of Health (R56MH108616, R01MH112588 and R01DK119814) to P. A. Graziano and A. S. Dick. This research was supported by a Computational Administrative Supplement to parent grant R01MH112588.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by The Health Sciences Institutional Review Board at the Office of Research Integrity at Florida International University, located in Miami, FL.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available on request due to privacy/ethical restrictions